by Robert Hayes Posted on June 28, 2022June 28, 2022 BUSINESS BRIEF: Wilmington’s Charles River Laboratories Announces Opening of U.K. Manufacturing Facility Read More
by Robert Hayes Posted on April 10, 2022April 10, 2022 Wilmington’s Charles River Laboratories Acquires Explora BioLabs Read More
by Robert Hayes Posted on March 28, 2022March 28, 2022 Wilmington’s Charles River Laboratories To Appoint Flavia H. Pease As Chief Financial Officer Read More
by Robert Hayes Posted on January 26, 2022January 27, 2022 BUSINESS BRIEF: Wilmington’s Charles River & Valo Health Announce Strategic Partnership To Provide Access To AI-Enabled Drug Discovery Solutions Read More
by Robert Hayes Posted on November 11, 2021November 12, 2021 BUSINESS BRIEF: Wilmington’s Charles River Laboratories Promotes Birgit Girshick To Chief Operating Officer Read More
by Robert Hayes Posted on July 3, 2021July 3, 2021 BUSINESS BRIEF: Wilmington’s Charles River Laboratories Acquires Vigene Biosciences For $292.5 Million Read More
by Robert Hayes Posted on May 17, 2021May 17, 2021 BUSINESS BRIEF: Wilmington’s Charles River Labs To Acquire Vigene Biosciences To Enhance Gene Therapy Capabilities Read More
by Robert Hayes Posted on April 6, 2021April 6, 2021 BUSINESS BRIEF: Wilmington’s Charles River Laboratories Completes Acquisition Of Cognate BioServices For $875 Million Read More
by Robert Hayes Posted on April 5, 2021April 5, 2021 BUSINESS BRIEF: Wilmington’s Charles River Laboratories Acquires Retrogenix Read More
by Robert Hayes Posted on February 21, 2021February 21, 2021 BUSINESS BRIEF: Wilmington’s Charles River Laboratories To Acquire Cognate BioServices For $875 Million Read More
by Robert Hayes Posted on January 16, 2021January 16, 2021 BUSINESS BRIEF: Charles River Partners With JADE Biomedical To Expand Biologics Capabilities Read More
by Robert Hayes Posted on January 5, 2021January 5, 2021 BUSINESS BRIEF: Wilmington’s Charles River Laboratories Acquires Distributed Bio Read More
You must be logged in to post a comment.